Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charalampos Papadopoulos

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cardiovascular & Hematological Disorders Drug Targets|April 15, 2025
Molecular and Immunometabolic Landscape of Erythrophagocytosis-induced FerroptosisCharalampos Papadopoulos
Endocrine, Metabolic & Immune Disorders Drug Targets|May 4, 2022
Erythrocyte Glucotoxicity Results in Vascular InflammationCharalampos Papadopoulos
Cardiovascular & Hematological Disorders Drug Targets|November 26, 2021
Lipotoxicity Disrupts Erythrocyte Function: A PerspectiveCharalampos Papadopoulos, Ioannis Tentes, Konstantinos Anagnostopoulos
Maedica|December 20, 2021
Molecular Interactions between Erythrocytes and the Endocrine SystemCharalampos Papadopoulos, Ioannis Tentes, Konstantinos Anagnostopoulos
Maedica|February 19, 2021
Red Blood Cell Dysfunction in Non-Alcoholic Fatty Liver Disease: Marker and Mediator of Molecular MechanismsCharalampos Papadopoulos, Ioannis Tentes, Konstantinos Anagnostopoulos
Endocrine, Metabolic & Immune Disorders Drug Targets|November 5, 2020
Immune and Metabolic Interactions of Human Erythrocytes: A Molecular PerspectiveCharalampos Papadopoulos, Maria Panopoulou, Konstantinos Anagnostopoulos, et al.
Viral Immunology|November 7, 2022
Red Blood Cell Malfunction in COVID-19: Molecular Mechanisms and Therapeutic TargetsCharalampos Papadopoulos, Eleftheria Spourita, Ioannis Tentes, et al.
Maedica|September 21, 2020
Cholesterol and Phospholipid Distribution Pattern in the Erythrocyte Membrane of Patients with Hepatitis C and Severe Fibrosis, before and after Treatment with Direct Antiviral Agents: A pilot StudyCharalampos Papadopoulos, Maria Panopoulou, Theodora Mylopoulou, et al.
Metabolic Syndrome and Related Disorders|May 9, 2022
Nonalcoholic Fatty Liver Disease Patients Exhibit Reduced CD47 and Increased Sphingosine, Cholesterol, and Monocyte Chemoattractant Protein-1 Levels in the Erythrocyte MembranesCharalampos Papadopoulos, Eleftheria Spourita, Konstantinos Mimidis, et al.
Reports of Biochemistry & Molecular Biology|June 29, 2022
Red Blood Cell-Conditioned Media from Non-Alcoholic Fatty Liver Disease Patients Contain Increased MCP1 and Induce TNF-α ReleaseCharalampos Papadopoulos, Konstantinos Mimidis, Dimitris Papazoglou, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cardiovascular & Hematological Disorders Drug Targets|April 15, 2025
Molecular and Immunometabolic Landscape of Erythrophagocytosis-induced FerroptosisCharalampos Papadopoulos
Endocrine, Metabolic & Immune Disorders Drug Targets|May 4, 2022
Erythrocyte Glucotoxicity Results in Vascular InflammationCharalampos Papadopoulos
Cardiovascular & Hematological Disorders Drug Targets|November 26, 2021
Lipotoxicity Disrupts Erythrocyte Function: A PerspectiveCharalampos Papadopoulos, Ioannis Tentes, Konstantinos Anagnostopoulos
Maedica|December 20, 2021
Molecular Interactions between Erythrocytes and the Endocrine SystemCharalampos Papadopoulos, Ioannis Tentes, Konstantinos Anagnostopoulos
Maedica|February 19, 2021
Red Blood Cell Dysfunction in Non-Alcoholic Fatty Liver Disease: Marker and Mediator of Molecular MechanismsCharalampos Papadopoulos, Ioannis Tentes, Konstantinos Anagnostopoulos
Endocrine, Metabolic & Immune Disorders Drug Targets|November 5, 2020
Immune and Metabolic Interactions of Human Erythrocytes: A Molecular PerspectiveCharalampos Papadopoulos, Maria Panopoulou, Konstantinos Anagnostopoulos, et al.
Viral Immunology|November 7, 2022
Red Blood Cell Malfunction in COVID-19: Molecular Mechanisms and Therapeutic TargetsCharalampos Papadopoulos, Eleftheria Spourita, Ioannis Tentes, et al.
Maedica|September 21, 2020
Cholesterol and Phospholipid Distribution Pattern in the Erythrocyte Membrane of Patients with Hepatitis C and Severe Fibrosis, before and after Treatment with Direct Antiviral Agents: A pilot StudyCharalampos Papadopoulos, Maria Panopoulou, Theodora Mylopoulou, et al.
Metabolic Syndrome and Related Disorders|May 9, 2022
Nonalcoholic Fatty Liver Disease Patients Exhibit Reduced CD47 and Increased Sphingosine, Cholesterol, and Monocyte Chemoattractant Protein-1 Levels in the Erythrocyte MembranesCharalampos Papadopoulos, Eleftheria Spourita, Konstantinos Mimidis, et al.
Reports of Biochemistry & Molecular Biology|June 29, 2022
Red Blood Cell-Conditioned Media from Non-Alcoholic Fatty Liver Disease Patients Contain Increased MCP1 and Induce TNF-α ReleaseCharalampos Papadopoulos, Konstantinos Mimidis, Dimitris Papazoglou, et al.
Pageof 2